JPRN-UMIN000023145
Completed
Phase 1
Examination of the effectiveness and safety of multidisciplinary therapy with docetaxel for high-risk prostate cancer - Multidisciplinary therapy with docetaxel for high-risk prostate cancer
Conditionsprostate cancer
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- prostate cancer
- Sponsor
- Juntendo University Hospital
- Enrollment
- 100
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\.Males under the age of 20\. 2\. Refuses to give informed consent. 3\. Refuses or is unable to have pelvic MRI or CT scan. 4\. Without criteria for administration of docetaxel. 5\. Deemed higher risk of administration of docetaxel by urologists or other physicians.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Evaluation of the safety and effectiveness of the MID-C/ApiFix system in adolescent idiopathic scoliosis.Spinal curvature1002837710005944NL-OMON43676Vrije Universiteit Medisch Centrum33
Active, not recruiting
Not Applicable
Safety and effectiveness clinical evaluation of the range of injectable medical devices HYDRAGEL C in facial aesthetic treatmentSubjects across groups present with moderate to severe facial aesthetic concerns, including peri-oral lines, nasolabial folds, lip volume deficits, and cheeks/cheekbones volume deficit, as gauged by various dermatological scalesSkin and Connective Tissue DiseasesISRCTN13586698ouna Aesthetics75
Active, not recruiting
Not Applicable
Clinical study to evaluate the safety and effectiveness of the use of two hyaluronic acid injectable products (Perfectha® Derm Lidocaine and Perfectha® Deep Lidocaine) in the treatment of lipsFor Perfectha® Derm Lidocaine: very thin to thin lip volume and with lip contour somewhat well-defined to poorly definedfor Perfectha® Deep Lidocaine: thin to moderate lip volumeNot ApplicableISRCTN72858148Sinclair Pharma68
Not yet recruiting
Phase 4
euroEPO in mild-moderate Alzheimer's disease amnesic variantmild-moderate Alzheimer's diseaseAlzheimer DiseaseDementiaBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesTauopathiesNeurodegenerative DiseasesNeurocognitive DisordersMental DisordersRPCEC00000410Center of Molecular Immunology (CIM)1,456
Recruiting
Phase 1
Investigating the endolift method in the treatment of primary axillary hyperhidrosisIRCT20200127046282N43Tehran University of Medical Sciences10